Oxbow Advisors, LLC Pfizer Inc Transaction History

Oxbow Advisors, LLC

$891 Million
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$25.89 - $29.73 $22,601 - $25,954	873 Added 6.0%	15,431 $428,000
Q4 2023 Feb 08, 2024	SELL	$26.13 - $33.94 $3.57 Million - $4.64 Million	-136,724 Reduced 90.38%	14,558 $419,000
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $4.23 Million - $4.94 Million	131,821 Added 677.36%	151,282 $5.02 Million
Q2 2023 Aug 04, 2023	BUY	$36.12 - $41.79 $22,286 - $25,784	617 Added 3.27%	19,461 $713,000
Q1 2023 Apr 25, 2023	SELL	$39.39 - $51.28 $10,162 - $13,230	-258 Reduced 1.35%	18,844 $768,000
Q4 2022 Feb 01, 2023	BUY	$41.75 - $54.5 $167 - $218	4 Added 0.02%	19,102 $979,000
Q3 2022 Nov 03, 2022	SELL	$43.76 - $53.42 $202,390 - $247,067	-4,625 Reduced 19.5%	19,098 $836,000
Q2 2022 Aug 10, 2022	SELL	$46.53 - $55.17 $9,119 - $10,813	-196 Reduced 0.82%	23,723 $1.24 Million
Q1 2022 May 09, 2022	SELL	$45.75 - $56.69 $165,981 - $205,671	-3,628 Reduced 13.17%	23,919 $1.24 Million
Q4 2021 Feb 09, 2022	BUY	$41.32 - $61.25 $165 - $245	4 Added 0.01%	27,547 $1.63 Million
Q3 2021 Nov 10, 2021	BUY	$39.25 - $50.42 $87,802 - $112,789	2,237 Added 8.84%	27,543 $1.19 Million
Q2 2021 Aug 04, 2021	SELL	$35.91 - $40.68 $8.43 Million - $9.55 Million	-234,691 Reduced 90.27%	25,306 $991,000
Q1 2021 May 11, 2021	SELL	$33.49 - $37.77 $1.28 Million - $1.45 Million	-38,325 Reduced 12.85%	259,997 $9.42 Million
Q4 2020 Feb 02, 2021	BUY	$33.47 - $42.56 $5,221 - $6,639	156 Added 0.05%	298,322 $11 Million
Q3 2020 Nov 06, 2020	SELL	$31.75 - $37.25 $215,614 - $252,964	-6,791 Reduced 2.23%	298,166 $10.9 Million
Q2 2020 Aug 12, 2020	BUY	$30.12 - $36.54 $5.5 Million - $6.67 Million	182,577 Added 149.19%	304,957 $9.97 Million
Q1 2020 May 06, 2020	SELL	$27.03 - $38.62 $29,597 - $42,288	-1,095 Reduced 0.89%	122,380 $3.99 Million
Q4 2019 Feb 06, 2020	SELL	$32.92 - $37.36 $125,425 - $142,341	-3,810 Reduced 2.99%	123,475 $4.84 Million
Q3 2019 Oct 31, 2019	BUY	$32.49 - $42.13 $236,332 - $306,453	7,274 Added 6.06%	127,285 $4.57 Million
Q2 2019 Aug 07, 2019	BUY	$36.98 - $41.52 $56,616 - $63,567	1,531 Added 1.29%	120,011 $5.2 Million
Q1 2019 May 01, 2019	SELL	$37.5 - $41.2 $199,762 - $219,472	-5,327 Reduced 4.3%	118,480 $5.03 Million
Q4 2018 Feb 12, 2019	SELL	$38.47 - $43.86 $4.65 Million - $5.3 Million	-120,898 Reduced 49.41%	123,807 $5.4 Million
Q3 2018 Nov 06, 2018	SELL	$34.47 - $41.81 $146,290 - $177,441	-4,244 Reduced 1.7%	244,705 $10.8 Million
Q2 2018 Aug 09, 2018	BUY	$32.98 - $35.16 $55,637 - $59,314	1,687 Added 0.68%	248,949 $9.03 Million
Q1 2018 Apr 30, 2018	BUY	$31.91 - $37.02 $153,519 - $178,103	4,811 Added 1.98%	247,262 $8.78 Million
Q4 2017 Jan 30, 2018	SELL	$33.26 - $35.29 $86,675 - $91,965	-2,606 Reduced 1.06%	242,451 $8.78 Million
Q3 2017 Oct 23, 2017	BUY	$31.0 - $34.15 $7.6 Million - $8.37 Million	245,057	245,057 $8.75 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$13.7 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.3 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$7.67 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.44 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

117M
Shares

$3.13 Billion
0.63% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oxbow Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oxbow Advisors, LLC with notifications on news.

Account